Similar articles for PMID: 28253524

Year	Number of Results
2004	1
2008	8
2009	16
2010	12
2011	20
2012	22
2013	30
2014	37
2015	23
2016	33
2017	26
2018	30
2019	30
2020	25
2021	30
2022	25
2023	10
2024	0

1

Intracrine androgen biosynthesis in renal cell carcinoma.

Lee GT, Han CS, Kwon YS, Patel R, Modi PK, Kwon SJ, Faiena I, Patel N, Singer EA, Ahn HJ, Kim WJ, Kim IY. Lee GT, et al. Br J Cancer. 2017 Mar 28;116(7):937-943. doi: 10.1038/bjc.2017.42. Epub 2017 Mar 2. Br J Cancer. 2017. PMID: 28253524 Free PMC article.

2

Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.

Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz CT, Evans CP, Gao AC. Liu C, et al. Clin Cancer Res. 2014 Jun 15;20(12):3198-3210. doi: 10.1158/1078-0432.CCR-13-3296. Epub 2014 Apr 16. Clin Cancer Res. 2014. PMID: 24740322 Free PMC article.

3

Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.

Ming DS, Pham S, Deb S, Chin MY, Kharmate G, Adomat H, Beheshti EH, Locke J, Guns ET. Ming DS, et al. J Steroid Biochem Mol Biol. 2014 Sep;143:19-28. doi: 10.1016/j.jsbmb.2014.02.006. Epub 2014 Feb 22. J Steroid Biochem Mol Biol. 2014. PMID: 24565566

4

Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.

Schmidt A, Meissner RS, Gentile MA, Chisamore MJ, Opas EE, Scafonas A, Cusick TE, Gambone C, Pennypacker B, Hodor P, Perkins JJ, Bai C, Ferraro D, Bettoun DJ, Wilkinson HA, Alves SE, Flores O, Ray WJ. Schmidt A, et al. J Steroid Biochem Mol Biol. 2014 Sep;143:29-39. doi: 10.1016/j.jsbmb.2014.02.005. Epub 2014 Feb 22. J Steroid Biochem Mol Biol. 2014. PMID: 24565564

5

Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts.

Knuuttila M, Mehmood A, Huhtaniemi R, Yatkin E, Häkkinen MR, Oksala R, Laajala TD, Ryberg H, Handelsman DJ, Aittokallio T, Auriola S, Ohlsson C, Laiho A, Elo LL, Sipilä P, Mäkelä SI, Poutanen M. Knuuttila M, et al. Am J Pathol. 2018 Jan;188(1):216-228. doi: 10.1016/j.ajpath.2017.08.036. Epub 2017 Nov 7. Am J Pathol. 2018. PMID: 29126837 Free article.

6

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.

Titus MA, Zeithaml B, Kantor B, Li X, Haack K, Moore DT, Wilson EM, Mohler JL, Kafri T. Titus MA, et al. PLoS One. 2012;7(1):e30192. doi: 10.1371/journal.pone.0030192. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272301 Free PMC article.

7

Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.

Moll JM, Hofland J, Teubel WJ, de Ridder CMA, Taylor AE, Graeser R, Arlt W, Jenster GW, van Weerden WM. Moll JM, et al. Prostate. 2022 Apr;82(5):505-516. doi: 10.1002/pros.24297. Epub 2022 Jan 17. Prostate. 2022. PMID: 35037287 Free PMC article.

8

Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.

Khurana N, Talwar S, Chandra PK, Sharma P, Abdel-Mageed AB, Mondal D, Sikka SC. Khurana N, et al. Int J Oncol. 2016 Oct;49(4):1609-19. doi: 10.3892/ijo.2016.3641. Epub 2016 Aug 2. Int J Oncol. 2016. PMID: 27499349

9

Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.

Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO. Dondoo TO, et al. Anticancer Res. 2017 Jan;37(1):125-134. doi: 10.21873/anticanres.11297. Anticancer Res. 2017. PMID: 28011482

10

Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer.

Porter LH, Bakshi A, Pook D, Clark A, Clouston D, Kourambas J; MURAL Investigators; Goode DL, Risbridger GP, Taylor RA, Lawrence MG. Porter LH, et al. J Pathol. 2021 Jun;254(2):121-134. doi: 10.1002/path.5652. Epub 2021 Mar 29. J Pathol. 2021. PMID: 33620092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year